Book a demo
Wiesner Healthcare v. Schedule A Defendants — Male Incontinence Clamp Patents | PatSnap
Explore in Eureka
Case ID1:24-cv-03777
FiledMay 2024
ClosedOct 2024
Patent Litigation

Wiesner Healthcare v. Schedule A Defendants: Default Judgment on Male Incontinence Clamp Patents

Wiesner Healthcare Innovation LLC secured a default judgment against 21 e-commerce defendants operating on Amazon, eBay, Temu, and Walmart for willful infringement of three patented external male incontinence clamp designs. The court awarded $37,816.91 per defaulting defendant — including trebled damages and attorney’s fees — closing the case in just 160 days.

Resolution time
160days
160 days from filing to default judgment — faster than the median patent case disposition in Illinois federal courts
Patents asserted
3
US10624728B2, US11351020B2, and US11642205B2 — external male incontinence clamp devices
Outcome
Default Judgment
Plaintiff win on all counts; defendants failed to appear; allegations deemed admitted
Cost ruling
Fees Awarded
Case deemed exceptional; $14,155.33 in attorney’s fees awarded under 35 U.S.C. § 285
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

E-commerce clamp infringers face treble damages and permanent injunction

Filed on 8 May 2024 in the Illinois Southern District Court before Judge Sharon Johnson Coleman, this action was brought by Wiesner Healthcare Innovation LLC against a Schedule A roster of anonymous e-commerce sellers operating storefronts on Amazon, eBay, Temu, and Walmart. The complaint alleged willful infringement of three federally registered patents — US10624728B2, US11351020B2, and US11642205B2 — all covering external male incontinence clamp products, alongside trade dress infringement and Illinois common law claims of unjust enrichment and unfair competition.

The case concluded on 15 October 2024 via default judgment after none of the 21 defaulting defendants answered or appeared. The court found personal jurisdiction on the basis that defendants actively targeted Illinois consumers through interactive e-commerce stores offering U.S. shipping. Damages were computed as a $10,000 reasonable royalty per defendant plus $2,380.95 in hypothetical negotiation transaction costs, with both sums subsequently trebled under 35 U.S.C. § 284, resulting in a total of $37,816.91 per defendant including attorney’s fees.

The 160-day resolution is consistent with the accelerated timelines typically seen in Schedule A e-commerce enforcement actions, where default is the norm rather than the exception. The willfulness finding — supported by claim chart evidence and screenshot documentation — enabled trebling and an exceptional case fee award, maximising plaintiff’s recovery without contested litigation. The public record does not disclose the total funds actually recovered from frozen marketplace accounts, nor the identities of the specific defendants listed on Schedule A.

Case at a glance
Case no.1:24-cv-03777
CourtIllinois Southern
JudgeSharon Johnson Coleman
FiledMay 8, 2024
ClosedOctober 15, 2024
Duration160 days
OutcomeDefault Judgment
Verdict causeInfringement Action
BasisDefault Judgment
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Illinois Southern District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Default Judgment in 160 days

160 days from filing to default judgment — faster than the median patent case disposition in Illinois federal courts

Case timeline: Complaint filed MAY 8 2024, JUL–AUG — 160 days total Horizontal timeline showing the three key events in Wiesner Healthcare Innovation, LLC v The Individuals, Corporations, Limited Liability Companies, Partnerships, and Unincorporated Associations Identified on the Attached Schedule A from filing to resolution. Source: PACER, Illinois Southern District Court. MAY 8 2024 Complaint filed Pre-trial proceedings OCT 15 2024 Default Judgment 160 DAYS TOTAL
Default judgment

Default judgment granted: what the ruling means for both parties

Legal mechanism

Default judgment: uncontested liability on all six counts

When defendants fail to appear or answer, the court may enter default judgment under Federal Rule of Civil Procedure 55. Here, all factual allegations — including willful infringement of three patents, trade dress infringement, and Illinois common law violations — were deemed admitted. The court independently verified personal jurisdiction and damages calculations before entering judgment, consistent with standard default judgment procedure in Schedule A patent cases.

Fed. R. Civ. P. 55 default
Patent holder outcome

Wiesner secures treble damages and a permanent injunction

Wiesner Healthcare obtained a permanent injunction barring manufacture, sale, and importation of infringing products, plus $37,816.91 per defendant comprising trebled royalties, transaction cost damages, and attorney’s fees. Marketplace platforms including Amazon, PayPal, and Temu were ordered to freeze and release defendant funds within seven to fourteen days. The exceptional case finding under § 285 further validates Wiesner’s enforcement posture and strengthens its position in any future actions against similar infringers.

Full relief granted
Defendant outcome

Non-appearance results in maximum exposure for e-commerce sellers

By failing to respond, the 21 defaulting defendants forfeited any opportunity to contest validity, non-infringement, or damages quantum. Each now faces a permanent injunction, frozen marketplace accounts, and a judgment debt of $37,816.91 — collectible through ongoing supplemental proceedings under Fed. R. Civ. P. 69. The default also precludes relitigation of the admitted facts, making any future challenge to liability procedurally difficult without vacating the default itself.

Full liability admitted by default
Commercial implications

Schedule A enforcement: a replicable model for medical device IP owners

This judgment illustrates how patent holders with products widely counterfeited on e-commerce platforms can leverage Schedule A actions for rapid, cost-effective enforcement. The combination of preliminary injunction, account freezing via third-party providers, and default judgment creates strong deterrence. For competitors and marketplace sellers in the incontinence device space, this ruling signals that Wiesner’s patent portfolio is actively enforced and that marketplace presence alone is sufficient to establish jurisdiction in Illinois.

Active Schedule A enforcement posture
Legal analysis based on PACER docket records for case 1:24-cv-03777 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffWiesner Healthcare Innovation, LLCCompanyMedical device IP holder — patents on external male incontinence clamp technologySearch in Eureka ↗
DefendantThe Individuals, Corporations, Limited Liability Companies, Partnerships, and Unincorporated Associations Identified on the Attached Schedule AIndividualAnonymous e-commerce sellers on Amazon, eBay, Temu, and Walmart — identified only on Schedule ASearch in Eureka ↗
Plaintiff counselBenjamin Adam CampbellAttorneyCounsel for Wiesner Healthcare Innovation, LLCSearch in Eureka ↗
Plaintiff counselEdward L. BishopAttorneyCounsel for Wiesner Healthcare Innovation, LLCSearch in Eureka ↗
Plaintiff counselNicholas S. LeeAttorneyCounsel for Wiesner Healthcare Innovation, LLCSearch in Eureka ↗
Plaintiff counselSameeul HaqueAttorneyCounsel for Wiesner Healthcare Innovation, LLCSearch in Eureka ↗
Plaintiff law firmBishop Diehl & Lee, Ltd.Law FirmRepresenting Wiesner Healthcare Innovation, LLCSearch in Eureka ↗
Presiding judgeJudge Sharon Johnson ColemanJudgeIllinois Southern District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“This action having been commenced by Plaintiff Wiesner Healthcare Innovation LLC, (“Plaintiff”) against the defendants identified on Schedule A, and using the Online Marketplace Accounts identified on Schedule A (collectively, the “Defendant Internet Stores”), and Plaintiff having moved for entry of Default and Default Judgment against the defendants identified on Schedule A, attached hereto which have not yet been dismissed from this case (collectively, “Defaulting Defendants”); This Court having entered a preliminary injunction; Plaintiff having properly completed service of process on Defaulting Defendants, the combination of providing notice via e-mail, along with any notice that Defaulting Defendants received from online marketplaces and payment processors, being notice reasonably calculated under all circumstances to apprise Defaulting Case: 1:24-cv-03777 Document #: 53 Filed: 10/15/24 Page 1 of 9 PageID #:1073 2 Defendants of the pendency of the action and affording them the opportunity to answer and present their objections; and None of the Defaulting Defendants having answered or appeared in any way, and the time for answering having expired, so that the allegations of the Complaint are uncontroverted and are deemed admitted; This Court finds that it has personal jurisdiction over Defaulting Defendants because Defaulting Defendants directly target their business activities toward consumers in the United States, including Illinois. Specifically, Plaintiff has provided a basis to conclude that Defaulting Defendants have targeted sales to Illinois residents by setting up and operating e-commerce stores that target United States consumers using one or more seller aliases, offer shipping to the United States, including Illinois, and have sold products that infringe upon Plaintiff’s federally registered patents, as claimed in U.S. Patent Nos. 10,624,728 B2 (“the ‘728 Patent”); 11,351,020 B2 (“the ‘020 Patent”); and 11,642,205 B2 (“the ‘205 Patent”) (collectively, “Plaintiff’s Patents”) to residents of Illinois. In this case, Plaintiff has presented screenshot evidence that each Defendant e-commerce store is reaching out to do business with Illinois residents by operating one or more commercial, interactive internet stores through which Illinois residents can and do purchase products that infringe Plaintiff’s Patents. See Schedule A and Exhibit 3 to the Verified Amended Complaint, Docket Nos. [14-1] and [14-6], which includes links and product ID numbers for the subject storefronts and infringing products and screenshot evidence confirming that each Defendant e-commerce store does stand ready, willing and able to ship its infringing products to customers in Illinois; see also Exhibit 7 to the Verified Amended Complaint, Docket No. [14-7], which contains exemplary claim charts outlining how Unauthorized Products infringe at least Claim 1 of each of Plaintiff’s Patents. Case: 1:24-cv-03777 Document #: 53 Filed: 10/15/24 Page 2 of 9 PageID #:1074 3 This Court further finds that Defaulting Defendants are liable for willful patent infringement on each of the three patent infringement claims (Counts I, II, and III), trade dress infringement (Count IV), and unjust enrichment and unfair competition under Illinois common law (Counts V and VI) in Plaintiff’s Verified Amended Complaint. Accordingly, this Court orders that Plaintiff’s Motion for Entry of Default and Default Judgment is GRANTED as follows, that Defaulting Defendants are deemed in default, and that this Default Judgment is entered against Defaulting Defendants. This Court further orders that: 1. Defaulting Defendants, their officers, agents, servants, employees, attorneys, and all persons acting for, with, by, through, under, or in active concert with them be permanently enjoined and restrained from: a. Making, using offering for sale, selling, and/or importing into the United States for subsequent sale any products that infringe upon Plaintiff’s Patents or use of any product that infringes upon Plaintiff’s Patents in any manner in connection with the distribution, marketing, advertising, offering for sale, or sale of any product that is not a genuine Plaintiff product or not authorized by Plaintiff to be sold in connection with Plaintiff’s Patents; b. using Plaintiff’s trade dress or any reproductions, infringing copies, or colorable imitations in any manner in connection with the distribution, marketing, advertising, offering for sale, or sale of any product that is not Plaintiff’s genuine product or not authorized by Plaintiff for sale under Plaintiff’s trade dress; c. passing off, inducing, or enabling others to sell or pass off any product as a genuine Plaintiff product or any other product produced by Plaintiff, that is not Plaintiff’s or not Case: 1:24-cv-03777 Document #: 53 Filed: 10/15/24 Page 3 of 9 PageID #:1075 4 produced under the authorization, control, or supervision of Plaintiff and approved by Plaintiff for sale that is protected under Plaintiff’s Patents or Plaintiff’s trade dress; d. committing any acts calculated to cause consumers to believe that Defaulting Defendants’ products are those sold under the authorization, control, or supervision of Plaintiff, or are sponsored by, approved by, or otherwise connected with Plaintiff and its rights in Plaintiff’s Patents; and e. manufacturing, shipping, delivering, holding for sale, transferring or otherwise moving, storing, distributing, returning, or otherwise disposing of, in any manner, products or inventory not manufactured by or for Plaintiff, nor authorized by Plaintiff to be sold or offered for sale, and which embody any of the Claims of Plaintiff’s Patents or which use Plaintiff’s trade dress. 2. Defaulting Defendants and any third party with actual notice of this Order who is providing services for any of the Defaulting Defendants, or in connection with any of the Defaulting Defendants’ Online Marketplaces, including, without limitation, any online marketplace platforms such as Amazon.com, Inc. (“Amazon”), eBay, Inc. (“eBay”), WhaleCo, Inc., (“Temu”), and Walmart, Inc. (“Walmart”), (collectively, the “Third Party Providers”), shall within seven (7) calendar days of receipt of this Order cease: a. using, linking to, transferring, selling, exercising control over, or otherwise owning the Online Marketplace Accounts, or any other online marketplace account that is being used to sell or is the means by which Defaulting Defendants could continue to sell goods that infringe upon Plaintiff’s Patents or Plaintiff’s trade dress; and Case: 1:24-cv-03777 Document #: 53 Filed: 10/15/24 Page 4 of 9 PageID #:1076 5 b. operating and/or hosting websites that are involved with the distribution, marketing, advertising, offering for sale, or sale of any product infringing Plaintiff’s Patents or Plaintiff’s trade dress or any reproductions, copies or colorable imitations thereof that is not a genuine Plaintiff product or not authorized by Plaintiff to utilize the inventions claimed in Plaintiff’s Patents or Plaintiff’s trade dress. 3. Upon Plaintiff’s request, those with notice of this Order, including the Third-Party Providers as defined in Paragraph 2, shall within seven (7) calendar days after receipt of such notice, disable and cease displaying any advertisements used by or associated with Defaulting Defendants in connection with the sale of infringing goods using the inventions claimed in Plaintiff’s Patents or using Plaintiff’s trade dress. 4. Pursuant to 35 U.S.C. § 284, Plaintiff is awarded damages equal to a reasonable royalty from each of the Defaulting Defendants in the amount of $10,000.00. 5. Pursuant to 35 U.S.C. § 284, Plaintiff is awarded expected transaction costs associated with the hypothetical negotiations and drafting of royalty and licensing agreements between it and the twenty-one (21) Defaulting Defendants listed below. Plaintiff is awarded $50,000.00 in expected transaction costs, or $2,380.95 per Defaulting Defendant. 6. Pursuant to 35 U.S.C. § 284, Defaulting Defendants are subject to treble damages and Plaintiff is awarded three times the amount awarded in both paragraphs 4 and 5. 7. Additionally, this case is held exceptional, and Plaintiff is awarded its reasonable attorney’s fees pursuant to 35 U.S.C. § 285. This Court finds that an award of $14,155.33 in attorneys’ fees is reasonable, $674.06 per Defaulting Defendant, and therefore awards Plaintiff $14,155.33 in attorneys’ fees, $674.06 from each of the Defaulting Defendants. Case: 1:24-cv-03777 Document #: 53 Filed: 10/15/24 Page 5 of 9 PageID #:1077 6 8. As a result of the damages awarded to Plaintiff in paragraphs 4 through 7 of this Order, the total awarded to the Plaintiff is $37,816.91 per Defaulting Defendant. 9. Any Third-Party Providers holding funds for Defaulting Defendants, including Amazon, eBay, PayPal, Inc. (“PayPal”), Payoneer Global, Inc. (“Payoneer”), Temu, and Walmart, shall, within seven (7) calendar days of receipt of this Order, permanently restrain and enjoin any accounts connected to Defaulting Defendants or the Defendant Internet Stores from transferring or disposing of any funds (up to the total damages and attorneys’ fees awarded in Paragraph 4 through 8 above) or other of Defaulting Defendants’ assets. 10. All monies (up to the total damages and attorneys’ fees awarded in Paragraph 4 through 8 above) currently restrained in Defaulting Defendants’ financial accounts, including monies held by Third-Party Providers such as Amazon, eBay, PayPal, Payoneer, Temu, and Walmart, are hereby released to Plaintiff as partial payment of the above-identified damages, and Third Party Providers, including Amazon, eBay, PayPal, Payoneer, Temu, and Walmart, are ordered to release to Plaintiff the amounts from Defaulting Defendants’ financial accounts within fourteen (14) calendar days of receipt of this Order. 11. Until Plaintiff has recovered full payment of monies owed to it by any Defaulting Defendant, Plaintiff shall have the ongoing authority to commence supplemental proceedings under Federal Rule of Civil Procedure 69. 12. In the event that Plaintiff identifies any additional online marketplace accounts or financial accounts owned by Defaulting Defendants, Plaintiff may send notice of any supplemental proceeding, including a citation to discover assets, to Defaulting Defendants by e-mail at the e-mail addresses identified in Exhibit 3 to Verified Amended Complaint and any e-mail addresses provided for Defaulting Defendants by third parties. Case: 1:24-cv-03777 Document #: 53 Filed: 10/15/24 Page 6 of 9 PageID #:1078 7 13. The ten-thousand dollar ($10,000.00) surety bond posted by Plaintiff is hereby released to Plaintiff or its counsel, Bishop Diehl & Lee, Ltd. The Clerk of the Court is directed to return the surety bond previously deposited with the Clerk of the Court to Plaintiff or its counsel. This is a Default Judgment.”
Source: PACER Docket, Case 1:24-cv-03777, Illinois Southern District Court

The default judgment encompasses liability on all six counts — three patent infringement claims, trade dress infringement, unjust enrichment, and unfair competition — with damages trebled under 35 U.S.C. § 284 and attorney’s fees awarded under § 285. The court’s willfulness finding, grounded in claim chart evidence rather than a contested trial, carries the same legal weight as a jury willfulness verdict for enforcement and collection purposes. The permanent injunction binds not only defendants but any party acting in concert with them, extending practical reach to future storefronts operated under new aliases.

PACER case 1:24-cv-03777 · Public docket record Explore in Eureka ↗
Patent at issue

US10624728B2, US11351020B2 & US11642205B2 — External Male Incontinence Clamp

Publication No.US10624728B2
Application No.US15/253051
Patent details
ProductExternal male incontinence clamp — foundational device design
Cited in actionMay 8, 2024

Publication No.US11351020B2
Application No.US17/305844
Patent details
ProductExternal male incontinence clamp — continuation covering further configurations
Cited in actionMay 8, 2024

Publication No.US11642205B2
Application No.US16/810148
Patent details
ProductExternal male incontinence clamp — continuation covering additional embodiments
Cited in actionMay 8, 2024

The three asserted patents — US10624728B2, US11351020B2, and US11642205B2 — form a continuation family protecting external male incontinence clamp devices, a non-surgical product worn externally to manage urinary incontinence in male patients. The family spans application numbers US15/253051, US17/305844, and US16/810148, suggesting successive prosecution rounds designed to broaden or diversify claim coverage against evolving product designs. This device category occupies a commercially active segment of the urology and continence care market, where price-competitive imports are common.

A three-patent continuation family in this space is commercially significant: each successive patent may cover design variations that could otherwise serve as workarounds to the foundational claims. For medical device companies, distributors, and e-commerce sellers offering male incontinence clamps, the active enforcement demonstrated in this case — with claim charts already filed against marketplace products — raises the competitive risk profile substantially. Any product in this category entering the U.S. market should be evaluated against all three patents’ independent claims before launch.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should you run an FTO against US10624728B2, US11351020B2 & US11642205B2?

Any company designing, importing, or selling external male incontinence clamp products in the United States — particularly via Amazon, eBay, Temu, or Walmart — should treat an FTO analysis against Wiesner’s three-patent family as a commercial necessity following this judgment. The court’s willingness to find personal jurisdiction based solely on marketplace shipping reach means that geographic distance provides no safe harbour. The claim charts already filed in this case provide a ready roadmap to the asserted claim scope.

PatSnap Eureka’s FTO Search Agent can map your product’s design against the independent and dependent claims of all three Wiesner patents simultaneously, identify claim elements that require design-around analysis, and surface related prior art that may support a validity challenge. Given the active enforcement posture evidenced by this case, commissioning an FTO before listing any male incontinence clamp product on U.S. marketplaces is the commercially prudent step.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US10624728B2 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar Schedule A patent cases: medical device e-commerce enforcement in Illinois

Browse comparable Schedule A patent enforcement actions in the Illinois federal courts involving medical device and healthcare product patents asserted against online marketplace sellers.

🔍
Access 40+ similar cases in PatSnap Eureka
Wiesner Healthcare Innovation, LLC patent enforcement history, Illinois Southern case history, Wiesner Healthcare Innovation, LLC’s full IP portfolio, and comparable case analysis
Illinois Schedule A defaultsMedical device IP enforcementAmazon patent injunctionsTreble damages § 284 cases
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the medical device e-commerce IP landscape

Wiesner’s swift default judgment sets a precedent for how medical device IP holders can neutralise anonymous online infringers at scale.

Marketplace account freezing is the real enforcement lever in Schedule A cases

Orders directing Amazon, eBay, PayPal, Payoneer, Temu, and Walmart to freeze and transfer funds give patent holders immediate practical relief before defendants can withdraw assets. For IP owners with products selling on multiple platforms, building a Schedule A enforcement programme with pre-drafted account-freeze orders is now a strategic baseline, not an advanced tactic.

Treble damages and § 285 fees are reliably available when defendants default

Courts in the Northern District of Illinois have consistently found wilfulness and exceptional case status in Schedule A defaults where plaintiffs supply claim charts and screenshot evidence. Wiesner’s $10,000 base royalty plus transaction costs, trebled, shows that structuring damages arguments carefully — even in uncontested proceedings — meaningfully increases recovery per defendant and deters future infringement.

🔒
Full strategic analysis in PatSnap Eureka
Unlock deeper analysis on medical device patent enforcement strategy at district court level, including claim scope and marketplace risk signals.
Portfolio claim mappingMarketplace IP risk exposureSchedule A filing strategy
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Wiesner v Individuals — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Track medical device patent enforcement before it reaches your products

Wiesner’s three-patent portfolio is actively enforced against U.S. marketplace sellers. Use PatSnap Eureka to run an FTO against all three continuation patents and set monitoring alerts for new Schedule A actions in the incontinence device space.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.